相似文献
1
Cancer chemoprevention locks onto a new polyamine metabolic target.
Cancer Prev Res (Phila). 2010 Feb;3(2):125-7. doi: 10.1158/1940-6207.CAPR-09-0252. Epub 2010 Jan 26.
2
Chemoprevention of B-cell lymphomas by inhibition of the Myc target spermidine synthase.
Cancer Prev Res (Phila). 2010 Feb;3(2):140-7. doi: 10.1158/1940-6207.CAPR-09-0166. Epub 2010 Jan 26.
3
Polyamine metabolism as target for cancer chemoprevention (review).
Int J Oncol. 1998 Nov;13(5):993-1006. doi: 10.3892/ijo.13.5.993.
4
Novel Inhibitors of Ornithine Decarboxylase of Leishmania Parasite (LdODC): The Parasite Resists LdODC Inhibition by Overexpression of Spermidine Synthase.
Chem Biol Drug Des. 2016 Mar;87(3):352-60. doi: 10.1111/cbdd.12665. Epub 2015 Oct 13.
5
RNA interference-mediated silencing of ornithine decarboxylase and spermidine synthase genes in Trypanosoma brucei provides insight into regulation of polyamine biosynthesis.
Eukaryot Cell. 2009 May;8(5):747-55. doi: 10.1128/EC.00047-09. Epub 2009 Mar 20.
6
Polyamine metabolism and cancer.
J Cell Mol Med. 2003 Apr-Jun;7(2):113-26. doi: 10.1111/j.1582-4934.2003.tb00210.x.
7
The putrescine analogue 1-aminooxy-3-aminopropane perturbs polyamine metabolism in the phytopathogenic fungus Sclerotinia sclerotiorum.
Arch Microbiol. 2003 Sep;180(3):169-75. doi: 10.1007/s00203-003-0572-1. Epub 2003 Jul 8.
8
Role of propylamine transferases in hormone-induced stimulation of polyamine biosynthesis.
Biochem J. 1980 Oct 15;192(1):59-63. doi: 10.1042/bj1920059.
9
Polyamines and their biosynthetic enzymes in Ehrlich ascites-carcinoma cells. Modification of tumour polyamine pattern by diamines.
Biochem J. 1977 Jul 15;166(1):89-94. doi: 10.1042/bj1660089.
10
Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors.
Curr Drug Targets. 2003 Oct;4(7):537-64. doi: 10.2174/1389450033490885.
引用本文的文献
1
The tumor-nerve circuit in breast cancer.
Cancer Metastasis Rev. 2023 Jun;42(2):543-574. doi: 10.1007/s10555-023-10095-1. Epub 2023 Mar 31.
2
Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.
BMC Cancer. 2021 Jan 7;21(1):31. doi: 10.1186/s12885-020-07734-z.
3
Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers.
Commun Biol. 2019 Nov 14;2:414. doi: 10.1038/s42003-019-0666-1. eCollection 2019.
4
Quantitative metabolomics for investigating the value of polyamines in the early diagnosis and therapy of colorectal cancer.
Oncotarget. 2017 Dec 4;9(4):4583-4592. doi: 10.18632/oncotarget.22885. eCollection 2018 Jan 12.
5
Plasma N-acetylputrescine, cadaverine and 1,3-diaminopropane: potential biomarkers of lung cancer used to evaluate the efficacy of anticancer drugs.
Oncotarget. 2017 Jul 17;8(51):88575-88585. doi: 10.18632/oncotarget.19304. eCollection 2017 Oct 24.
6
c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma.
Oncotarget. 2016 Oct 4;7(40):65514-65539. doi: 10.18632/oncotarget.11804.
7
The Dysregulation of Polyamine Metabolism in Colorectal Cancer Is Associated with Overexpression of c-Myc and C/EBPβ rather than Enterotoxigenic Bacteroides fragilis Infection.
Oxid Med Cell Longev. 2016;2016:2353560. doi: 10.1155/2016/2353560. Epub 2016 Jun 28.
8
ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers.
Am J Cancer Res. 2016 Jun 1;6(6):1231-52. eCollection 2016.
9
Dietary polyamine intake and colorectal cancer risk in postmenopausal women.
Am J Clin Nutr. 2015 Aug;102(2):411-9. doi: 10.3945/ajcn.114.103895. Epub 2015 Jul 1.
10
Polyamine metabolism is sensitive to glycolysis inhibition in human neuroblastoma cells.
J Biol Chem. 2015 Mar 6;290(10):6106-19. doi: 10.1074/jbc.M114.619197. Epub 2015 Jan 15.
本文引用的文献
1
Chemoprevention of B-cell lymphomas by inhibition of the Myc target spermidine synthase.
Cancer Prev Res (Phila). 2010 Feb;3(2):140-7. doi: 10.1158/1940-6207.CAPR-09-0166. Epub 2010 Jan 26.
2
A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.
Cancer Prev Res (Phila). 2010 Jan;3(1):35-47. doi: 10.1158/1940-6207.CAPR-09-0096.
3
Formation of the first peptide bond: the structure of EF-P bound to the 70S ribosome.
Science. 2009 Aug 21;325(5943):966-70. doi: 10.1126/science.1175800.
4
Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor.
J Med Chem. 2009 Apr 9;52(7):1983-93. doi: 10.1021/jm801580w.
5
Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas.
Cancer Prev Res (Phila). 2009 Mar;2(3):209-12. doi: 10.1158/1940-6207.CAPR-08-0203. Epub 2009 Mar 3.
6
Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation.
Clin Cancer Res. 2009 Feb 1;15(3):758-61. doi: 10.1158/1078-0432.CCR-08-2235.
7
Longitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas.
Cancer Prev Res (Phila). 2008 Dec;1(7):514-21. doi: 10.1158/1940-6207.CAPR-08-0074.
8
An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer.
Cell. 2008 Nov 28;135(5):852-64. doi: 10.1016/j.cell.2008.09.061. Epub 2008 Nov 13.
9
Myc's broad reach.
Genes Dev. 2008 Oct 15;22(20):2755-66. doi: 10.1101/gad.1712408.
10
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.
Cancer Prev Res (Phila). 2008 Jun;1(1):32-8. doi: 10.1158/1940-6207.CAPR-08-0042.
Zotero 插件